Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Performance Evaluation of a Novel Non-Invasive Monitoring Device for At-Home Neutropenia Detection in a Multicenter Cancer Cohort.
Journal: American journal of hematology
Published: April 07, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026
Serum S100A8/S100A9 is associated with increased risk of brain metastasis in patients with inflammatory breast cancer.
Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026
Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.
Journal: ESMO open
Published: November 04, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease).
Journal: Therapeutic advances in medical oncology
Published: August 28, 2025
Retrospective review of metastatic hormone receptor-positive inflammatory breast cancer patients reveals poor responses to cyclin dependent kinase 4/6 inhibition.
Journal: Breast cancer research : BCR
Published: June 11, 2025
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study.
Journal: Breast cancer research and treatment
Published: May 10, 2025
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 23, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations.
Journal: bioRxiv : the preprint server for biology
Published: June 25, 2024
Last Updated: 09/26/2026